Literature DB >> 1271518

Synthesis of the adenovirus-coded DNA binding protein in infected cells.

Z Gilead, K Sugawara, G Shanmugam, M Green.   

Abstract

Synthesis of the 75K (75K indicates a moleculatr weight of 70,000 to 75,000) DNA binding protein, an early virus-coded protein in adenovirus 2-infected KB cells, and its regulation were studied by using a radioimmune precipitation inhibition assay. The protein was first detected at 4 h postinfection and accumulated at an expoential rate. An arrest of further synthesis (accumulation) was observed at 10 to 11 h postinfection, coinciding with the onset of synthesis of late virion proteins. In contrast, when the infected cells were treated with 25 mug of arabinosyl cytosine per ml to block viral DNA replication, the synthesis of 75K protein did not cease but continue for up to 36 h postinfection. The synthesis of 75K protein in cells after release from a cycloheximide block (2 to 9 h postinfection) was analyzed. Increased amounts of early adenovirus-specific mRNA accumulate in infected cells during a cycloheximide block (Parsons and Green, 1971). However, cycloheximide treatment did not produce increased levels of 75K protein, and an abrupt arrest of 75K protein formation was again observed at the time of synthesis of late virion proteins. Partition of the 75K protein between the nuclear and cytoplasmic fractions during the course of infection was studied. The 75K protein appeared first in the cytoplasm and then in the nucleus after a slight lag. Accumulation of the 75K protein continued both in the cytoplasm and nucleus, with higher levels being found in the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1271518      PMCID: PMC515570          DOI: 10.1128/JVI.18.2.454-460.1976

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Isolation and characterization of adenovirus type 12 DNA binding proteins.

Authors:  B Rosenwirth; K Shiroki; A J Levine; H Shimojo
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

2.  Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides.

Authors:  R W Honess; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

3.  Analysis of early adenovirus 2 RNA using Eco R-R1 viral DNA fragments.

Authors:  E A Craig
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

4.  Adenovirus polypeptide synthesis in the presence of non-replicating poliovirus.

Authors:  R Bablanian; W C Russell
Journal:  J Gen Virol       Date:  1974-08       Impact factor: 3.891

5.  Synthesis of virus-specific ribonucleic acid in KB cells infected with type 2 adenovirus.

Authors:  J J Lucas; H S Ginsberg
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

6.  Thermolabile DNA binding proteins from cells infected with a temperature-sensitive mutant of adenovrius defective in viral DNA synthesis.

Authors:  P C Van Der Vliet; A J Levine; M J Ensinger; H S Ginsberg
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

7.  Tumour antigen specificity of a DNA-binding protein from cells infected with adenovirus 2.

Authors:  Z Gilead; M Q Arens; S Bhaduri; G Shanmugam; M Green
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

8.  DNA-binding proteins specific for cells infected by adenovirus.

Authors:  P C van der Vliet; A J Levine
Journal:  Nat New Biol       Date:  1973-12-12

9.  DNA binding proteins in the cytoplasm and in a nuclear membrane complex isolated from uninfected and adenovirus 2 infected cells.

Authors:  G Shanmugam; S Bhaduri; M Arens; M Green
Journal:  Biochemistry       Date:  1975-01-28       Impact factor: 3.162

10.  Synthesis of type 2 adenovirus DNA in the presence of cycloheximide.

Authors:  M S Horwitz; C Brayton; S G Baum
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

View more
  9 in total

1.  The 55K protein on the 5' termini of adenovirus type 2 DNA is unrelated to virus-coded candidate transformation proteins (E1-53K, E1-40K-50K) and DNA-binding proteins (E2-42K/47K/73K).

Authors:  M Green; W S Wold; K H Brackmann; M A Cartas
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Genome expression and mRNA maturation at late stages of productive adenovirus type 2 infection.

Authors:  W S Wold; M Green; K H Brackmann; M A Cartas; C Devine
Journal:  J Virol       Date:  1976-11       Impact factor: 5.103

3.  Adenovirus type 2 coded single-stranded DNA binding protein: in vivo phosphorylation and modification.

Authors:  Y H Jeng; W S Wold; K Sugawara; Z Gilead; M Green
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

4.  Adenovirus type 2 early polypeptides immunoprecipitated by antisera to five lines of adenovirus-transformed rat cells.

Authors:  W S Wold; M Green
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

5.  Adenovirus DNA-binding protein in cells infected with wild-type 5 adenovirus and two DNA-minus, temperature-sensitive mutants, H5ts125 and H5ts149.

Authors:  H S Ginsberg; U Lundholm; T Linné
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

6.  Autoregulation of adenovirus type 5 early gene expression. III. Transcription studies in isolated nuclei.

Authors:  R A Blanton; T H Carter
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

7.  Immunofluorescence study of the adenovirus type 2 single-stranded DNA binding protein in infected and transformed cells.

Authors:  K Sugawara; Z Gilead; W S Wold; M Green
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

8.  Early gene expression of adenovirus type 2: R-loop mapping of mRNA and time course of viral DNA, mRNA, and protein synthesis.

Authors:  P D Neuwald; J Meyer; J V Maizel; H Westpahl
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

9.  Adenovirus-specific DNA-binding protein inhibits the hydrolysis of DNA by DNase in vitro.

Authors:  K Nass; G D Frenkel
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.